Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Capillary Microsampling for Therapeutic Drug Monitoring (TDM) of CDK4/6 Inhibitors in Breast Cancer Patients

NCT07491380 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT07491380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07491380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Capillary Microsampling for Therapeutic Drug Monitoring (TDM) of CDK4/6 Inhibitors in Breast Cancer Patients
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Recruiting
Start date
June 23, 2026
Completion date
January 23, 2029
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer